OnTheMove and Prana announce partnership

5 December 2022

OnTheMove Software and Prana Life Sciences Enter Into Partnership Agreement to Speed Up Clinical Trials for the Life Sciences Industry

For the pharmaceutical, biotech and medical device industries, reducing the amount of time required to complete clinical trials is critical not only for financial reasons, but also for saving and improving the quality of lives for patients. In this modern era, data collection and processing should not be an obstacle that causes delays in clinical trials. OnTheMove Software, a Veeva Technology partner, has developed a platform to address this issue which reduces the clinical trial timelines by reducing the time required to collect site visit data.

Prana Life Sciences, a Pennsylvania based IT Solutions provider, has entered into a partnership with OnTheMove as of December 1st, 2022. Prana Life Sciences, which is also a services partner of Veeva, will work with OnTheMove Software to offer support services for its Veeva Site Visit Reporting application. Prana will help to expand OnTheMove’s support services, enabling more clients in the life sciences industry to take advantage of its revolutionary technology.

As part of clinical trials, clinical research associates (CRAs) are sometimes required to travel to different facilities to conduct site visits and monitor clinical trial sites. There may be limited or no internet connection available on-site, so CRAs must sometimes take notes and then re-enter the information in a clinical trial management system (CTMS). OnTheMove Software has developed a solution for Veeva CTMS to address the need for offline visit reporting, which enables CRAs to capture data offline during site visits and then automatically upload the data to Veeva once they regain access to an internet connection. The OnTheMove user interface is optimized for smaller laptops and tablets and improves the user experience when entering data by minimizing scrolling, clicks and navigation. With OnTheMove, less time is spent on site visit reports and less training and support is required, leading to substantial savings of both time and cost during the clinical trials process.